Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial

被引：14

作者：

Aftimos, P. G. ^{[1
]}

Turner, N. ^{[2
]}

O'Shaughnessy, J. ^{[3
]}

van den Tweel, E. ^{[4
]}

Oesterholt, M. ^{[4
]}

Escriva-de-Romani, S. ^{[5
]}

Tueux, N. Quenel ^{[6
]}

Tan, T. J. Y. ^{[7
]}

Lim, J. ^{[8
]}

Ladoire, S. ^{[9
]}

Armstronh, A. C. ^{[10
]}

Stradella, A. ^{[11
]}

Bianchi, G. V. ^{[12
]}

Colleoni, M. A. ^{[13
]}

Kaczmarek, E. ^{[14
]}

Punie, K. ^{[15
]}

Song, X. ^{[16
]}

Koper, N. ^{[4
]}

Saura Manich, C. ^{[17
]}

机构：

[1] Inst Jules Bordet, Clin Trials Conduct Unit, Anderlecht, Belgium

[2] Royal Marsden Hosp Chelsea, London, England

[3] Baylor Sammons Canc Ctr, Texas Oncol, Dallas, TX USA

[4] Byondis BV, Clin Dev Dept, Nijmegen, Netherlands

[5] Vall dHebron Univ Hosp, Med Oncol, Breast Canc Unit, Barcelona, Spain

[6] Inst Bergonie, Bordeaux, France

[7] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore

[8] Natl Univ Hlth Syst, Med Oncol, Singapore, Singapore

[9] Ctr Georges Francois Leclerc Dijon, Dept Oncol, Dijon, France

[10] Christie NHS Fdn Trust, Manchester, Lancs, England

[11] Hosp Duran & Reynals, Med Oncol Dept, ICO Inst Catala Oncol Hosp, Lhospitalet De Llobregat, Spain

[12] Fdn IRCCS Ist Nazl Tumori Milano, Dept Med Oncol, SC Oncol Med 1, Milan, Italy

[13] Ist Europeo Oncol, Milan, Italy

[14] Ctr Oscar Lambret, Lille, France

[15] Univ Hosp Leuven, Leuven Canc Inst, Gen Med Oncol & Multidisciplinary Breast Ctr, Leuven, Belgium

[16] Ottawa Hosp Reg Canc Ctr, Dept Med Oncol, Ottawa, ON, Canada

[17] Vall dHebron Univ Hosp, Breast Canc Program, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.563

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

386MO

引用

页码：S340 / S341

页数：2